J&J Unit Recalls 40,000 Bottles Of Risperidone

Law360, New York (June 17, 2011, 6:32 PM EDT) -- Johnson & Johnson Inc. unit Ortho-McNeil-Janssen Pharmaceuticals on Friday announced a voluntary recall of 40,000 bottles of psychiatric drug risperidone over fears they are contaminated with a wood preservative byproduct.

The recall, which covers two lots of risperidone, stems from two consumer reports of an uncharacteristic odor linked to trace amounts of a chemical called TBA, J&J said. TBA, also known as also known as 2,4,6,-tribromoanisole, is a byproduct of a wood preservative often used in the construction of shipping pallets.

The TBA-linked recall is J&J's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.